Shubha Anand
Overview
Explore the profile of Shubha Anand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
890
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Massie C, Gnanapragasam V, Barrett T, Warren A, Anand S, Keates A, et al.
BJU Int
. 2023 Jul;
132(5):499-501.
PMID: 37431085
No abstract available.
2.
Dayimu A, Di Lisio L, Anand S, Roca-Carreras I, Qian W, Al-Mohammad A, et al.
Br J Cancer
. 2023 Feb;
128(9):1672-1680.
PMID: 36813867
Background: Chemotherapy for metastatic pancreatic adenocarcinoma (PDAC) offers limited benefits, but survival outcomes vary. Reliable predictive response biomarkers to guide patient management are lacking. Methods: Patient performance status, tumour burden...
3.
Agrawal-Singh S, Bagri J, Giotopoulos G, Azazi D, Horton S, Lopez C, et al.
Blood
. 2022 Dec;
141(14):1737-1754.
PMID: 36577137
HOXA9 is commonly upregulated in acute myeloid leukemia (AML), in which it confers a poor prognosis. Characterizing the protein interactome of endogenous HOXA9 in human AML, we identified a chromatin...
4.
Smyth E, Cozens K, Griffiths D, Clark K, Ewings S, Petty R, et al.
BMC Cancer
. 2022 Sep;
22(1):946.
PMID: 36050653
Background: For patients with oesophagogastric adenocarcinoma, surgery is the only curative option and despite the use of multimodality therapy, which combines it with chemotherapy and/or radiotherapy, more than 50% of...
5.
Zhou Y, Shalhoub R, Rogers S, Yu S, Gu M, Fabre M, et al.
Blood
. 2022 Jul;
140(14):1650-1655.
PMID: 35839449
No abstract available.
6.
Caeser R, Walker I, Gao J, Shah N, Rasso-Barnett L, Anand S, et al.
JCO Precis Oncol
. 2021 Feb;
5:145-152.
PMID: 33542970
No abstract available.
7.
Katz-Summercorn A, Anand S, Ingledew S, Huang Y, Roberts T, Galeano-Dalmau N, et al.
J Pathol Clin Res
. 2017 Nov;
3(4):258-267.
PMID: 29085666
The early detection and endoscopic treatment of patients with the dysplastic stage of Barrett's oesophagus is a key to preventing progression to oesophageal adenocarcinoma. However, endoscopic surveillance protocols are hampered...
8.
Anand S, Huntly B
Hematol Oncol Clin North Am
. 2012 Sep;
26(5):1017-35.
PMID: 23009935
The human myeloproliferative neoplasms (MPN) have long been associated with abnormal responses to cytokines and activation of signaling pathways, although the exact molecular mechanisms underlying these observations were unknown. This...
9.
Anand S, Stedham F, Gudgin E, Campbell P, Beer P, Green A, et al.
Blood
. 2011 Jun;
118(6):1610-21.
PMID: 21653937
Myeloproliferative neoplasms (MPNs) are associated with recurrent activating mutations of signaling proteins such as Janus kinase 2 (JAK2). However, the actual downstream signaling events and how these alter myeloid homeostasis...
10.
Anand S, Stedham F, Beer P, Gudgin E, Ortmann C, Bench A, et al.
Blood
. 2011 May;
118(1):177-81.
PMID: 21562050
The JAK2 V617F mutation is present in the majority of patients with a myeloproliferative neoplasm (MPN) and is sufficient to recapitulate an MPN in murine models. However, the consequences of...